---
title: "300194.SZ (300194.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/300194.SZ/news.md"
symbol: "300194.SZ"
name: "300194.SZ"
parent: "https://longbridge.com/en/quote/300194.SZ.md"
datetime: "2026-05-20T12:46:02.482Z"
locales:
  - [en](https://longbridge.com/en/quote/300194.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/300194.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/300194.SZ/news.md)
---

# 300194.SZ (300194.SZ) — Related News

### [Fuan Pharmaceutical: Revenue of 1.738 billion yuan in 2025, net profit down 72.49% year-on-year](https://longbridge.com/en/news/284103268.md)
*2026-04-26T07:51:22.000Z*
> Fuan Pharmaceutical announced that it expects revenue in 2025 to be 1.738 billion yuan, a year-on-year decrease of 27.31

### [Fuan Pharmaceutical's subsidiary has obtained a drug registration certificate](https://longbridge.com/en/news/282504626.md)
*2026-04-13T07:53:03.000Z*
> Fuan Pharmaceutical's wholly-owned subsidiary Tianheng Pharmaceutical recently obtained a drug registration certificate 

### [Fuan Pharmaceutical's subsidiary has received approval for a chemical raw material drug listing application](https://longbridge.com/en/news/277003423.md)
*2026-02-26T08:08:49.000Z*
> Fuan Pharmaceutical's wholly-owned subsidiary Ningbo Tianheng Pharmaceutical recently obtained approval from the Nationa

### [Taiwan Stock Market Dynamics: Strong Demand for New Drug Development and Technology, Further Advancements in Finance and Infrastructure](https://longbridge.com/en/news/274941034.md)
*2026-02-05T08:40:05.000Z*
> Taiwan's stock market dynamics show strong demand for new drug development and technology. Quanta Computer has made prog

### [Fuan Pharmaceutical: Expected net profit in 2025 to decrease by 64.26%-74.99% year-on-year](https://longbridge.com/en/news/274269985.md)
*2026-01-30T08:04:54.000Z*
> Fuan Pharmaceutical announced that it expects a net profit of 70 million to 100 million yuan for the fiscal year 2025, a

### [Fuan Pharmaceutical: Subsidiary receives drug registration certificate for Cefotetan Pivoxil Tablets](https://longbridge.com/en/news/274267809.md)
*2026-01-30T07:46:46.000Z*
> Fuan Pharmaceutical's wholly-owned subsidiary Qingyutang Pharmaceutical recently obtained the drug registration certific

### [Ruipu Lanjun invested 50 million yuan in Fuan Guolong for nearly 11% equity](https://longbridge.com/en/news/274065999.md)
*2026-01-29T00:43:00.000Z*
> Ruipu Lanjun announced an investment of 50 million yuan to acquire nearly 11% of Fuan Guolong's equity. Fuan Guolong foc

### [Fuan Pharmaceutical: Subsidiary receives drug registration certificate](https://longbridge.com/en/news/273686505.md)
*2026-01-26T10:30:45.000Z*
> Fuan Pharmaceutical announced that its wholly-owned subsidiary, Fuan Pharmaceutical Group Ningbo Tianheng Pharmaceutical